Nova Eye Medical(AU:EYE)
A$0.160.00 (0.00%)
AU:EYE
Nova Eye Medical financials statements
A$0.16
At close:0.00 (0.00%)
Want to see AU:EYE full AI Analyst Report?
Nova Eye Medical (EYE) Ratios
21 Followers
Nova Eye Medical Ratios
AU:EYE's free cash flow for Q4 2026 was AU$-944.00K. For the 2026 fiscal year, AU:EYE's free cash flow was decreased by AU$-98.00K and operating cash flow was AU$-846.00K. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.74 | 2.39 | 2.60 | 2.33 | 4.04 |
| Quick Ratio | 1.15 | 1.85 | 1.84 | 1.72 | 3.12 |
| Cash Ratio | 0.17 | 0.98 | 1.08 | 1.18 | 2.07 |
| Solvency Ratio | -0.30 | -0.90 | -0.68 | -1.81 | -0.91 |
| Operating Cash Flow Ratio | -0.56 | -1.19 | -1.38 | -1.07 | -1.21 |
| Short-Term Operating Cash Flow Coverage | -5.11 | 0.00 | 0.00 | 0.00 | -8.61 |
| Net Current Asset Value | AU$ 2.31M | AU$ 4.79M | AU$ 6.20M | AU$ 7.43M | AU$ 9.36M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.11 | 0.11 | 0.05 | 0.05 |
| Debt-to-Equity Ratio | 0.17 | 0.16 | 0.16 | 0.07 | 0.06 |
| Debt-to-Capital Ratio | 0.14 | 0.14 | 0.14 | 0.06 | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.51 | 1.40 | 1.40 | 1.31 | 1.20 |
| Debt Service Coverage Ratio | -2.89 | -56.86 | -85.41 | -239.67 | -12.45 |
| Interest Coverage Ratio | -28.41 | -71.18 | -128.11 | -219.43 | -154.38 |
| Debt to Market Cap | 0.02 | 0.00 | 0.00 | 0.00 | 0.02 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 |
| Net Debt to EBITDA | -0.65 | 0.23 | 0.47 | 0.40 | 0.77 |
| Profitability Margins | |||||
| Gross Profit Margin | 71.74% | 68.56% | 86.57% | 4.95% | -5.72% |
| EBIT Margin | -12.55% | -38.43% | -38.45% | -99.55% | -72.50% |
| EBITDA Margin | -6.33% | -30.70% | -25.63% | -86.06% | -58.96% |
| Operating Profit Margin | -12.55% | -38.43% | -38.45% | -69.60% | -73.85% |
| Pretax Profit Margin | -12.43% | -30.95% | -37.68% | -99.86% | -58.43% |
| Net Profit Margin | -12.43% | -30.95% | -37.68% | -89.83% | -56.03% |
| Continuous Operations Profit Margin | -12.43% | -30.95% | -37.68% | -89.83% | -56.03% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 89.95% | 95.89% |
| EBT Per EBIT | 99.04% | 80.55% | 98.02% | 143.49% | 79.12% |
| Return on Assets (ROA) | -20.07% | -34.18% | -29.42% | -50.38% | -20.47% |
| Return on Equity (ROE) | -30.35% | -47.76% | -41.21% | -65.94% | -24.66% |
| Return on Capital Employed (ROCE) | -27.24% | -52.67% | -37.06% | -49.20% | -30.16% |
| Return on Invested Capital (ROIC) | -26.25% | -51.16% | -36.34% | -43.11% | -27.99% |
| Return on Tangible Assets | -34.97% | -46.11% | -38.47% | -89.78% | -40.30% |
| Earnings Yield | -14.50% | -33.30% | -20.03% | -37.00% | -28.02% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.83 | 6.99 | 5.72 | 7.67 | 6.54 |
| Payables Turnover | 3.95 | 3.91 | 0.88 | 3.75 | 5.88 |
| Inventory Turnover | 3.04 | 3.27 | 0.73 | 4.25 | 4.00 |
| Fixed Asset Turnover | 13.23 | 4.04 | 5.98 | 7.21 | 4.54 |
| Asset Turnover | 1.62 | 1.10 | 0.78 | 0.56 | 0.37 |
| Working Capital Turnover Ratio | 6.19 | 3.60 | 2.68 | 1.70 | 0.80 |
| Cash Conversion Cycle | 81.26 | 70.48 | 147.42 | 36.23 | 85.06 |
| Days of Sales Outstanding | 53.48 | 52.19 | 63.86 | 47.62 | 55.82 |
| Days of Inventory Outstanding | 120.09 | 111.63 | 499.14 | 85.84 | 91.36 |
| Days of Payables Outstanding | 92.31 | 93.34 | 415.58 | 97.23 | 62.12 |
| Operating Cycle | 173.56 | 163.82 | 563.00 | 133.46 | 147.18 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.02 | -0.04 | -0.04 | -0.03 |
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.04 | -0.05 | -0.07 |
| Dividend Paid and CapEx Coverage Ratio | -13.29 | -14.44 | -17.50 | -8.40 | -0.84 |
| Capital Expenditure Coverage Ratio | -13.29 | -14.44 | -17.50 | -8.40 | -0.84 |
| Operating Cash Flow Coverage Ratio | -1.30 | -2.04 | -2.35 | -4.39 | -2.41 |
| Operating Cash Flow to Sales Ratio | -0.09 | -0.21 | -0.34 | -0.39 | -0.35 |
| Free Cash Flow Yield | -11.24% | -24.17% | -18.92% | -18.20% | -38.40% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.91 | -3.01 | -4.99 | -2.70 | -3.57 |
| Price-to-Sales (P/S) Ratio | 0.86 | 0.93 | 1.88 | 2.43 | 2.00 |
| Price-to-Book (P/B) Ratio | 2.09 | 1.43 | 2.06 | 1.78 | 0.88 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8.90 | -4.14 | -5.28 | -5.50 | -2.60 |
| Price-to-Operating Cash Flow Ratio | -9.57 | -4.42 | -5.59 | -6.15 | -5.71 |
| Price-to-Earnings Growth (PEG) Ratio | 0.12 | 0.20 | 0.09 | -0.03 | -0.05 |
| Enterprise Value Multiple | -14.18 | -2.80 | -6.87 | -2.42 | -2.62 |
| Enterprise Value | 31.30M | 25.17M | 41.09M | 35.44M | 20.70M |
| EV to EBITDA | -14.18 | -2.80 | -6.87 | -2.42 | -2.62 |
| EV to Sales | 0.90 | 0.86 | 1.76 | 2.08 | 1.55 |
| EV to Free Cash Flow | -9.32 | -3.83 | -4.95 | -4.71 | -2.01 |
| EV to Operating Cash Flow | -10.03 | -4.09 | -5.23 | -5.27 | -4.42 |
| Tangible Book Value Per Share | 0.02 | 0.05 | 0.07 | 0.06 | 0.08 |
| Shareholders’ Equity Per Share | 0.05 | 0.08 | 0.10 | 0.14 | 0.20 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.10 | 0.04 |
| Revenue Per Share | 0.12 | 0.12 | 0.11 | 0.11 | 0.09 |
| Net Income Per Share | -0.02 | -0.04 | -0.04 | -0.10 | -0.05 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.90 | 0.96 |
| Interest Burden | 0.99 | 0.81 | 0.98 | 1.00 | 0.81 |
| Research & Development to Revenue | 0.06 | 0.11 | 0.19 | 0.04 | 0.02 |
| SG&A to Revenue | 0.78 | 0.61 | 0.51 | 0.66 | 0.75 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
| Income Quality | 0.72 | 0.68 | 0.89 | 0.44 | 0.62 |
Currency in AUD

